Dr Adri Voogd (A.C.)
Recent publications
-
Tiels, L. M., Walstra, C. J. E. F., Voogd, A. C., van der Sangen, M. J. C., van Haren, E. L. W. G., Smidt, M. L., Nieuwenhuijzen, G. A. P., Schipper, R.-J., & Dutch Snapshot Res Grp (2026). Postoperative complications after salvage mastectomy and repeat breast-conserving surgery in patients with IBTR after previous breast-conserving surgery: a multicenter, retrospective cohort study. Breast Cancer Research and Treatment, 215(3), Article 71. https://doi.org/10.1007/s10549-026-07908-6More information about this publication
-
Vreven, L. W. A., Verheul, E. M., van Maaren, M. C., Doornkamp, F., Schipper, R. J., Siesling, S., Pharoah, P. D. P., Tjan-Heijnen, V. C. G., & Voogd, A. C. (2026). Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer population. Breast, 85, Article 104681. https://doi.org/10.1016/j.breast.2025.104681More information about this publication
-
Duijm, L. E. M., Van Der Veer, E. L., Van Beek, H. C., Setz-Pels, W., Smallenburg, V. V. B., Van Bommel, R. M. G., Coul-Froger, C. L. O. D., Gielens, M., Van Uden, D. J. P., & Voogd, A. C. (2026). Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based study. The Lancet Regional Health – Europe, 61, Article 101526. https://doi.org/10.1016/j.lanepe.2025.101526More information about this publication
-
Siermann, M., IsmaïliM'hamdi, H., Kerkhofs, T., Voogd, A. C., & de Wert, G. (2025). Multi-kankerscreening? Nederlands Tijdschrift voor Geneeskunde, 169. https://www.ntvg.nl/artikelen/multi-kankerscreeningMore information about this publication
-
Ding, N., Hermans, K. E. P. E., van Nijnatten, T. J. A., Engelen, S. M. E., Tol, J., Kooreman, L., Vrancken-Peeters, M. J. T. F. D., Siesling, S., Voogd, A. C., Tjan-Heijnen, V. C. G., & Geurts, S. M. E. (2025). Overall survival of patients with de Novo HER2-positive metastatic breast cancer in the Netherlands from 2008 to 2017: A population-based cohort study of systemically treated patients. European Journal of Cancer, 222, Article 115475. https://doi.org/10.1016/j.ejca.2025.115475More information about this publication
-
Walstra, C. J. E. F., Schipper, R. J., Voogd, A. C., van der Sangen, M. J. C., van Duin, R. T. N. W., van Riet, Y. E., Smidt, M. L., Bloemen, J. G., Wyndaele, D. N. J., Nieuwenhuijzen, G. A. P., & Dutch Snapshot Research Group (2025). The role of 18F-FDG PET/CT in detecting synchronous regional and distant metastatic disease in patients with an in-breast tumour recurrence. European Journal of Surgical Oncology, 51(5), Article 109564. https://doi.org/10.1016/j.ejso.2024.109564More information about this publication
-
van der Veer, E. L., Coolen, A. M. P., Bluekens, A. M. J., Generaal, M. I., Schipper, R. J., Setz-Pels, W., van Uden, D. J. P., Voogd, A. C., & Duijm, L. E. M. (2025). Interhospital variation in surgical treatment of screen-detected breast cancer in the South of the Netherlands. Breast, 80, Article 103886. https://doi.org/10.1016/j.breast.2025.103886More information about this publication
-
Ploumen, R. A. W., van Nijnatten, T. J. A., Kooreman, L. F. S., Voogd, A. C., Keymeulen, K. B. M. I., Siesling, S., & Smidt, M. L. (2025). Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component. Breast, 79, Article 103854. https://doi.org/10.1016/j.breast.2024.103854More information about this publication
-
van der Veer, E. L., Rozemond, F., Generaal, M. I., Bluekens, A. M. J., Coolen, A. M. P., Voogd, A. C., & Duijm, L. E. M. (2025). Interhospital variations in diagnostic work-up following recall at biennial screening mammography-a population-based study. European Radiology, 35(7), 3964–3978. https://doi.org/10.1007/s00330-024-11302-5More information about this publication
-
de Bruijn, A., Schipper, R.-J., Voogd, A. C., Pullens, M. J. J., Bloemen, J. G., de Munck, L., van Riet, Y. E., Siesling, S., Vriens, B. E. P., & Nieuwenhuijzen, G. A. P. (2024). Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study. Cancers, 16(24), Article 4188. https://doi.org/10.3390/cancers16244188More information about this publication